疑似肺癌患者行胸部X线检查可能有害
该研究分析基层医疗中疑似肺癌患者以胸部X线(CXR)作为一线检查的使用情况,纳入2018年6月至2019年5月16945例基层转诊CXR中的1488例疑似肺癌患者,按CX1(正常但建议CT排除恶性)、CX2(其他诊断)、CX3(可疑癌症)编码并行Kaplan-Meier生存分析。期间经基层CXR路径诊断肺癌101例,正常CXR(CX1)患者仅10%后续接受CT且肺癌诊断显著延迟(p<0.001),CX1、CX2、CX3患者分别有50%、38%、57%在晚期确诊(p=0.26),不同CX编码间无生存差异(p=0.42)。结论认为疑似肺癌检查中胸部X线可能有害。
要点
- 正常CXR报告(CX1)仅10%患者后续行CT,且肺癌诊断显著延迟(p<0.001)。
- CX1、CX2、CX3患者晚期确诊比例分别为50%、38%、57%(p=0.26),不同编码间无生存差异(p=0.42)。
- 1年期间半数肺癌诊断首先以胸部X线检查,正常CXR可能造成虚假安心并延误诊断。
核心结论
- 疑似肺癌患者行胸部X线检查可能有害,正常CXR可能造成虚假安心并将资源优先用于晚期病变。
- 正常CXR报告导致肺癌诊断显著延迟(p<0.001),不同CXR编码间无生存差异(p=0.42)。
研究设计与样本
- 研究分析基层医疗疑似肺癌患者以胸部X线(CXR)作为一线检查的使用情况。
- 2018年6月至2019年5月共16945例基层转诊CXR,其中1488例因疑似肺癌转诊。
- CXR编码为CX1(正常但建议CT排除恶性)、CX2(其他诊断)、CX3(可疑癌症),并按CX编码分层行Kaplan-Meier生存分析。
关键影像表现/征象
- CXR编码分为CX1正常但建议CT排除恶性、CX2其他诊断、CX3可疑癌症三类。
- 研究期间经基层CXR路径诊断肺癌101例。
诊断标准与关键数值
- CX1定义为CXR正常但建议CT扫描排除恶性,CX2为其他诊断,CX3为可疑癌症。
- CX1患者中仅10%后续接受CT。
- 晚期确诊比例:CX1患者50%、CX2患者38%、CX3患者57%(p=0.26)。
- 不同CX编码间生存无差异(p=0.42)。
临床应用与阅片要点
- 作者结论认为疑似肺癌检查中胸部X线可能有害。
- 作者认为该策略在CXR正常时可能造成虚假安心,并将资源优先用于晚期病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to analyse the use of the chest radiograph (CXR) as the first-line investigation in primary care patients with suspected lung cancer.
METHODS: Of 16,945 primary care referral CXRs (June 2018 to May 2019), 1,488 were referred for suspected lung cancer. CXRs were coded as follows: CX1, normal but a CT scan is recommended to exclude malignancy; CX2, alternative diagnosis; or CX3, suspicious for cancer. Kaplan-Meier survival analysis was undertaken by stratifying patients according to their CX code.
RESULTS: In the study period, there were 101 lung cancer diagnoses via a primary care CXR pathway. Only 10% of patients with a normal CXR (CX1) underwent subsequent CT and there was a significant delay in lung cancer diagnosis in these patients (p < 0.001). Lung cancer was diagnosed at an advanced stage in 50% of CX1 patients, 38% of CX2 patients and 57% of CX3 patients (p = 0.26). There was no survival difference between CX codes (p = 0.42).
CONCLUSION: Chest radiography in the investigation of patients with suspected lung cancer may be harmful. This strategy may falsely reassure in the case of a normal CXR and prioritises resources to advanced disease.
KEY POINTS: • Half of all lung cancer diagnoses in a 1-year period are first investigated with a chest X-ray. • A normal chest X-ray report leads to a significant delay in the diagnosis of lung cancer. • The majority of patients with a normal or abnormal chest X-ray have advanced disease at diagnosis and there is no difference in survival outcomes based on the chest X-ray findings.
引用
- Foley RW, Nassour V, Oliver HC, et al. Chest X-ray in suspected lung cancer is harmful. Eur Radiol. 2021. PMID: 33517491. doi:10.1007/s00330-021-07708-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。